Withdrawal scales for - alcohol

The CIWA-Ar

The Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) is a validated scoring tool assessing alcohol withdrawal severity across multiple symptom domains (tremor, sweating, anxiety, agitation, nausea, hallucinations, and others) - enabling symptom-triggered benzodiazepine dosing rather than a fixed dosing schedule regardless of individual severity
Widely used in hospital settings managing alcohol withdrawal, given alcohol withdrawal's potential severity (including seizures and delirium tremens) and the value of an objective, reproducible severity measure to guide treatment intensity

Alcohol withdrawal reflects CNS hyperexcitability following removal of chronic alcohol's GABA-potentiating, glutamate-suppressing effects - the structured, multi-domain CIWA-Ar score captures the range of resulting autonomic and neurological hyperexcitability symptoms, providing a more complete severity picture than any single symptom (e.g. tremor alone) would give

Symptom-triggered dosing (giving benzodiazepine doses guided by the current CIWA-Ar score at regular reassessment intervals) generally achieves adequate symptom control with lower total benzodiazepine exposure than fixed-schedule dosing, given individual variation in withdrawal severity and time course
Regular, scheduled reassessment (not just at admission) is essential given withdrawal severity can evolve significantly over the following hours to days

Benzodiazepine dosing titrated to CIWA-Ar score at each reassessment, with escalating dose/frequency for higher scores and de-escalation as symptoms resolve
High or rapidly rising scores, or scores in a patient with a prior severe withdrawal/seizure history, should prompt consideration of a higher level of monitoring/care given delirium tremens and seizure risk

Delirium tremens (the most severe withdrawal complication, associated with significant mortality if inadequately treated), alcohol withdrawal seizures, symptom-triggered vs fixed-schedule benzodiazepine dosing, prior severe withdrawal history predicting future severity

Symptom-triggered benzodiazepine dosing, guided by regular CIWA-Ar reassessment, generally achieves better outcomes than a fixed dosing schedule applied uniformly regardless of the individual patient's actual withdrawal severity - this individualised approach avoids both under-treatment (seizure/delirium tremens risk) and over-treatment (unnecessary sedation) that a one-size-fits-all schedule risks

5 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.